Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Dana-Farber Cancer Institute
MacroGenics
Kezar Life Sciences, Inc.
National Cancer Institute (NCI)
Tempus AI
Vedanta Biosciences, Inc.
Eisai Inc.
Day One Biopharmaceuticals, Inc.
Hoffmann-La Roche
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
NRG Oncology
NGM Biopharmaceuticals, Inc
Kymab Limited
Shattuck Labs, Inc.
Incyte Corporation
Seagen Inc.
University of Pittsburgh
Sarcoma Oncology Research Center, LLC
BerGenBio ASA
Stanford University
Pfizer
Rain Oncology Inc
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
National Cancer Institute (NCI)
Pfizer
Pfizer
ADC Therapeutics S.A.
Exelixis
Pfizer
Eli Lilly and Company
NextCure, Inc.
Eisai Inc.
Stanford University
Hoffmann-La Roche
Nektar Therapeutics
Nektar Therapeutics
Herlev Hospital
Karyopharm Therapeutics Inc
Ludwig Institute for Cancer Research
Incyte Corporation
Pfizer
Incyte Corporation
EMD Serono
Novartis
Incyte Corporation